Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001903596-25-000274
Filing Date
2025-05-19
Accepted
2025-05-19 08:40:43
Documents
79
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 kays_10ka.htm   iXBRL 10-K/A 1427444
2 ex31_1.htm EX-31.1 15320
3 ex32_1.htm EX-32.1 6734
9 GRAPHIC image_001.jpg GRAPHIC 3638
10 GRAPHIC image_035.jpg GRAPHIC 4595
  Complete submission text file 0001903596-25-000274.txt   7558499

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE kays-20241231.xsd EX-101.SCH 57116
5 XBRL CALCULATION FILE kays-20241231_cal.xml EX-101.CAL 73813
6 XBRL DEFINITION FILE kays-20241231_def.xml EX-101.DEF 171024
7 XBRL LABEL FILE kays-20241231_lab.xml EX-101.LAB 389706
8 XBRL PRESENTATION FILE kays-20241231_pre.xml EX-101.PRE 319377
82 EXTRACTED XBRL INSTANCE DOCUMENT kays_10ka_htm.xml XML 1479034
Mailing Address 915 MIDDLE RIVER DRIVE, SUITE 316 FORT LAUDERDALE FL 33304
Business Address 915 MIDDLE RIVER DRIVE, SUITE 316 FORT LAUDERDALE FL 33304 954-5347895
Kaya Holdings, Inc. (Filer) CIK: 0001530746 (see all company filings)

EIN.: 900898007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-177532 | Film No.: 25961613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)